https://youtu.be/X3gHzBI68dk Baylor University Medical Center Investigates Safety & Efficacy of Leronlimab in Severe to Critical COVID-19 Patients: Baylor University Medical Center prepares to initiate a clinical trial investigating leronlimab, an investigational...
Video
Category
Clinical Trials and Research News Weekly Roundup | Dr. Tarek Alam’s Ivermectin Working |S2 E30
https://youtu.be/tE7RqQR9f_w Bangladesh Medical College’s Dr. Tarek Alam’s Ivermectin Working 98% With Between 400-500 Patients & More Research to Come: Dr. Tarek Alam, a highly respected physician and professor of Medicine at Bangladesh Medical College (BMC),...
Investor Watch Series | S2 E4 | Largest Life Sciences Fund In History. Pharma Nervous?
https://youtu.be/XPCDSJVUIJA Welcome To Investor Watch In this series will be going over trials, research and other clinical verticals that receive funding. Below are the ones we cover in this episode: Blackstone Raises Largest Life Sciences PEG Fund in History &...
Clinical Trials and Research News Weekly Roundup | Doctor Claims Silver Bullet COVID-19 Treatment |S2 E29
https://youtu.be/eFCzeBiV3nc West Texas Doctor Claims of ‘Silver Bullet’ Off-Label Use of Inhaled Steroid as COVID-19 Treatment: A local West Texas doctor believes he has come up with an approach to effectively treat #COVID19. Dr. Richard Bartlett has practiced...
The Watchlist Series | Regeneron Comes Through on Promise & Initiates Investigation of REGN-COV2
https://youtu.be/_QzPelODvLQ Regeneron has received $450 million for an advanced investigational monoclonal antibody targeting COVID-19 called REG-COV2. According to the company’s public-facing statements, the two antibodies identified represented the most potent,...
Investor Watch Series | Funding – Who to Watch | Novavax ProFactor Pharma | CureVac | S2 E3
https://youtu.be/XPCDSJVUIJA Welcome To Investor Watch In this series will be going over trials, research and other clinical verticals that receive funding. Below are the ones we cover in this episode: U.S. Feds via Operation Warp Speed Injects $1.6b into Vaccine...
Clinical Trials and Research News Weekly Roundup | S2 E28 | Favipiravir Cut while Ivermectin Added
https://youtu.be/pmJI488eLMA Delhi’s #COVID-19 Provider Lok Nayak Hospital Cuts #Favipiravir & Adds Ivermectin & Remdesivir for COVID-19 Patients: Lok Nayak Hospital is the national capital’s first COVID-19 only facility. Although Favipiravir was recently...
The Watchlist Series | Kevzara Failure: Are IL-6 inhibitors the right approach for COVID-19?
https://youtu.be/gf_oY1WmYZM Welcome to another episode of the Watchlist Series. Today, we take a look at IL-6 Inhibitors, and whether or not, they are the right class of biologic to be testing on Covid-19 Patients. Regeneron and Sanofi announced that the U.S....
Investor Watch Series | Funding – Who to Watch | S2 E2
https://youtu.be/8IsCC8ws2hA Welcome To Investor Watch In this series will be going over trials, research and other clinical verticals that receive funding. Below are the ones we cover in this episode: Amylyx Pharmaceuticals Raises $30 Million in Series B Funding to...
Clinical Trials and Research News Weekly Roundup | S2 E27 | Ivermectin VS Hydroxychloroquine
https://youtu.be/VfTvViI8IKI Ivermectin Study Reveals Fantastic Results: 100% of 60 Patients Better in an Average of Just Under 6 Days: Recently, TrialSite News reported on a study sponsored in Bangladesh by Upazila Health & Family Planning Officer’s (UHFPO)...
The Watchlist Series: Trump’s Operation Warp Speed Picks Up Steam | S1 E12
https://youtu.be/pqlfJb31Uis Welcome To The Watchlist Series. Potential Game Changer: Operation Warp Speed Gains Momentum: Operation Warp Speed represents an impressive collaborative effort among federal government authority, agencies and initiatives that have an...
Investor Watch Series | Funding – Who to Watch | S2 E1 Purdue Seeks Biotech Partnerships
https://youtu.be/6jNGyGAVEPw Welcome To Investor Watch In this series will be going over trials, research and other clinical verticals that receive funding. Below are the ones we cover in this episode: #Purdue Spin-off Secures $400K for Novel Approach to Treating Lung...
Clinical Trials and Research News Weekly Roundup | S2 E27 | WHO and Ivermectin
https://youtu.be/dh9ke0KPCj4 WHO & Pan American Health Organization Position on Ivermectin Use & COVID-19: Produce Evidence via RCT In recent episodes, we’ve covered a plethora of stories about Ivermectin from around the globe. Recently, the Pan American...
Clinical Trials and Research News Weekly Roundup | S2 E26 | Famotidine May Address COVID-19
https://youtu.be/Mvqf9FgV_YI #Famotidine Leads to Improved #COVID19 Patient Outcomes based on Retrospective Case Series Led by Cold Spring Harbor Laboratory: A group of prominent New York-based physicians and scientists led by Cold Spring Harbor Laboratory, Northwell...
Clinical Trials and Research News Weekly Roundup | S2 E24
https://youtu.be/u6VPZaXnlPY Peru. A place that appears to be the epicenter of the movement for off-label use of #Ivermectin to treat #COVID-19 patients. The doctors there swear by it. In fact, some of them curse the government for not embracing the anti-parasite drug...
The Watchlist Series: Hydroxychloroquine And The Mysterious Surgisphere Database | S1 E11
https://youtu.be/yhO-ohPXWEA Welcome To The Watchlist Series. The #Hydroxychloroquine, Chloroquine story and how controversial this anti-malarial drug has been. At the start of the #COVID-19 pandemic it seemed like an accepted standard of care. After all why would...
Clinical Trials and Research News Weekly Roundup | S2 E24 | China COVID-19 Vaccine
https://youtu.be/F_0_RxFcIp8 00:41 #China’s Beijing Institute of Biological Product’s COVID-19 Vaccine Reportedly Ready for Phase III? One of the leading COVID-19 vaccine candidates could be available as soon as the end of this year, reported the WeChat account of a...
The Watchlist Series: Covid-19, And The Ivermectin Situation | S1 E10
https://youtu.be/Q7pqyKGsgJU Welcome To The Watchlist Series. TrialSite News’ interview with Tarek Alam, head of medicine department at Bangladesh Medical College, has led to considerable interest in regional hospital protocol-approved, off-label use of Ivermectin and...
Clinical Trials and Research News Weekly Roundup | S2 E23 | Oxford Vaccine
https://youtu.be/U2RD98RWtK8 00:27 #AstraZeneca Full-Throttle with the Oxford Vaccine Including $1B from BARDA Despite Some Concerning Chatter: AstraZeneca has received over $1 billion from the United States government, via BARDA investment, to support development and...
Clinical Trials and Research News Weekly Roundup | S2 E22
https://youtu.be/t4uWISON57A Bangladesh Medical College Hospital Physician See ‘Astounding Results’ with Drug Combination Targeting COVID-19: A popular Indian financial news platform liveMint recently reported that physicians from Bangladesh Medical College Hospital...